Latest From GluMetrics Inc.
Start-ups developing technologies to help hospitals avoid preventable medical errors known as “never events” are developing solutions to nosocomial infections, retained surgical objects, pressure ulcers, and medication errors.
Over a decade ago, the New England Journal of Medicine published a study identifying tight glycemic control in the intensive care unit as a critical step to improving patient outcomes. Today, a small pack of companies is trying to finally deliver on the promise.
Over a decade ago, the New England Journal of Medicine published a study identifying tight glycemic control in the intensive care unit as a critical step to improving outcomes. Today, GlySure and others are working on continuous glucose monitoring for the critical care environment to help deliver on that promise.
A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.
- Monitoring Equipment & Devices
- Therapeutic Areas
- Metabolic Disorders
- North America
- Parent & Subsidiaries
- GluMetrics Inc.
- Senior Management
William H Markle, CEO
Stuart Gallant, VP, Product Dev.
Paul Gasser, VP, Reg. Affairs
- Contact Info
Phone: (949) 579-1376
15375 Barranca Pkwy., Ste. I-108
Irvine, CA 92618
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.